127 related articles for article (PubMed ID: 10622414)
1. Increased biological potency of hexafluorinated analogs of 1,25-dihydroxyvitamin D3 on bovine parathyroid cells.
Imanishi Y; Inaba M; Seki H; Koyama H; Nishizawa Y; Morii H; Otani S
J Steroid Biochem Mol Biol; 1999; 70(4-6):243-8. PubMed ID: 10622414
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo.
Miyahara T; Harada M; Kozakai A; Matsumoto M; Hashimoto K; Inoue H; Yoda K; Nakatsu T; Kajita S; Yamazaki R; Higuchi S; Kozuka H; Nemoto N
J Nutr Sci Vitaminol (Tokyo); 1999 Jun; 45(3):239-49. PubMed ID: 10524344
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
4. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
[TBL] [Abstract][Full Text] [Related]
5. Involvement of polyamines in the proliferation of bovine parathyroid cells.
Imanishi Y; Inaba M; Nishizawa Y; Morii H; Otani S
Miner Electrolyte Metab; 1995; 21(1-3):197-200. PubMed ID: 7565449
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of F6-1alpha,25(OH)2 vitamin D3 and 1alpha,25(OH)2 vitamin D3 in the parathyroid glands of rats dosed with tritium-labeled compounds.
Komuro S; Sato M; Kanamaru H
Drug Metab Dispos; 2003 Aug; 31(8):973-8. PubMed ID: 12867483
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
Miyahara T; Gomyo S; Ueda Y; Ohyama Y; Sigeno C; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Yamamoto M; Sakuma T; Nemoto N
Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
[TBL] [Abstract][Full Text] [Related]
8. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
[TBL] [Abstract][Full Text] [Related]
9. A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells.
Miyahara T; Simoura T; Osahune N; Uchida Y; Sakuma T; Nemoto N; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Chiba H; Iba K; Sawada N
Calcif Tissue Int; 2002 Jun; 70(6):488-95. PubMed ID: 12016462
[TBL] [Abstract][Full Text] [Related]
10. Hexafluoro-1,25-dihydroxyvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3.
Chen TC; Holick MF
Br J Dermatol; 2000 Jul; 143(1):72-8. PubMed ID: 10886138
[TBL] [Abstract][Full Text] [Related]
11. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3.
Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N
Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297
[TBL] [Abstract][Full Text] [Related]
12. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
Honda A; Nakashima N; Shida Y; Mori Y; Nagata A; Ishizuka S
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
[TBL] [Abstract][Full Text] [Related]
13. Effects of 1,25-dihydroxyvitamin D3 and cortisol on bovine and human parathyroid cells.
Karmali R; Farrow S; Hewison M; Barker S; O'Riordan JL
J Endocrinol; 1989 Oct; 123(1):137-42. PubMed ID: 2553843
[TBL] [Abstract][Full Text] [Related]
14. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
Inaba M; Okuno S; Inoue A; Nishizawa Y; Morii H; DeLuca HF
Arch Biochem Biophys; 1989 Jan; 268(1):35-9. PubMed ID: 2463789
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture.
Cantley LK; Russell J; Lettieri D; Sherwood LM
Endocrinology; 1985 Nov; 117(5):2114-9. PubMed ID: 3840080
[TBL] [Abstract][Full Text] [Related]
16. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
[TBL] [Abstract][Full Text] [Related]
17. Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3.
Inaba M; Okuno S; Nishizawa Y; Imanishi Y; Katsumata T; Sugata I; Morii H
Biochem Pharmacol; 1993 Jun; 45(11):2331-6. PubMed ID: 8517874
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion.
Cantley LK; Russell JB; Lettieri DS; Sherwood LM
Calcif Tissue Int; 1987 Jul; 41(1):48-51. PubMed ID: 3040201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]